参考文献/References:
［1］GIUDICE L CClinical practice.Endometriosis ［J］. New England Journal of Medicine, 2010, 362 (25) : 2389-2398.
［2］中华医学会妇产科学分会子宫内膜异位症协作组．子宫内膜异位症的诊治指南 ［J］．中华妇产科杂志，2015，50（3）：161-169．
［3］RUIZ A, ROCKFIELD S, TARAN N, et al. Effect of hydroxychloroquine and characterization of autophagy in a mouse model of endometriosis ［J］. Cell Death & Disease, 2016, 7(1): e2059-e2077.
［4］TAYLOR R N, YU Jie, TORRES P B, et al. Mechanistic and therapeutic implications of angiogenesis in endometriosis ［J］. Reproductive Sciences, 2009, 16 (2) : 140-146.
［5］SANTULLI P, MARCELLIN L, TOSTI C, et al. MAP kinases and the inflammatory signaling cascade as targets for the treatment of endometriosis ［J］. Expert Opinion on Therapeutic Targets, 2015, 19 (11) : 1465-1483.
［6］BROWNE A S, YU Jie, HUANG Ruo-pan, et al. Proteomic identification of neurotrophins in the eutopic endometrium of women with endometriosis ［J］. Fertility and Sterility, 2012, 98 (3): 713-719.
［7］Borghese B, Vaiman D, Mondon F, et al.Neurotrophins and pain in endometriosis ［J］. Gynecol Obstet Fertil，2010，38 (7-8) : 442-446.
［8］ANGER D L, ZHANG Bingjun, BOUTROSS-TADROSS O, et al. Tyrosine receptor kinase B (TrkB) protein expression in the human endometrium ［J］. Endocrine, 2007, 31 (2) : 167-173.
［9］DEWANTO A, DUDAS J, GLUECKERT R, et al. Localization of TrkB and p75 receptors in peritoneal and deep infiltrating endometriosis: an immunohistochemical study ［J］. Reproductive Biology and Endocrinology : RB&E, 2016, 14 (1): 43.
［10］YU Xiao-hui, LIU Ling, CAI Bin, et al. Suppression of anoikis by the neurotrophic receptor TrkB in human ovarian cancer ［J］. Cancer Science, 2008, 99 (3): 543-552.
［11］BAI Huimin, LI Haixia, LI Weihua, et al. The PI3K/AKT/mTOR pathway is a potential predictor of distinct invasive and migratory capacities in human ovarian cancer cell lines ［J］. Oncotarget, 2015, 6 (28): 25520-25532.
［12］LECONTE M, NICCO C, NG C, et al. The mTOR/AKT inhibitor temsirolimus prevents deep infiltrating endometriosis in mice ［J］. The American Journal of Pathology, 2011, 179 (2) : 880-889.
［13］SMITH E D, PRIETO G A, TONG Liqi, et al. Rapamycin and interleukin-1β impair brain-derived neurotrophic factor-dependent neuron survival by modulating autophagy ［J］. The Journal of Biological Chemistry, 2014, 289 (30): 20615-20629.
［14］LEE I I, KIM J J. Influence of AKT on progesterone action in endometrial diseases ［J］. Biology of Reproduction, 2014, 91(3): 63.
［15］KIM T H, YU Yanni, LUO L, et al. Activated AKT pathway promotes establishment of endometriosis ［J］. Endocrinology, 2014, 155 (5): 1921-1930.
［16］EATON J L, UNNO K, CARAVEO M, et al. Increased AKT or MEK1/2 activity influences progesterone receptor levels and localization in endometriosis ［J］. The Journal of Clinical Endocrinology and Metabolism, 2013, 98 (12): E1871-E1879.
［17］BLAIS M, LVESQUE P, BELLENFANT S, et al. Nerve growth factor, brain-derived neurotrophic factor, neurotrophin-3 and glial-derived neurotrophic factor enhance angiogenesis in a tissue-engineered in vitro model ［J］. Tissue Engineering Part a, 2013, 19 (15/16): 1655-1664.
［18］USUI T, NARUO A, OKADA M, et al. Brain-derived neurotrophic factor promotes angiogenic tube formation through generation of oxidative stress in human vascular endothelial cells ［J］. Acta Physiologica (Oxford, England), 2014, 211 (2): 385-394.
［19］HUANG Feng-ying, CAO Jing, LIU Qiu-hong, et al. MAPK/ERK signal pathway involved expression of COX-2 and VEGF by IL-1β induced in human endometriosis stromal cells in vitro ［J］. International Journal of Clinical and Experimental Pathology, 2013, 6 (10): 2129-2136.
［20］CORDEIRO C A, VIEIRA E L, ROCHA N P, et al. Serum levels of neurotrophic factors in active toxoplasmic retinochoroiditis ［J］. The Brazilian Journal of Infectious Diseases : an Official Publication of the Brazilian Society of Infectious Diseases, 2016,20 (12):30584-30590.
［21］BUROTTO M, CHIOU V L, LEE J M, et al. The MAPK pathway across different malignancies: a new perspective ［J］. Cancer, 2014, 120 (22) : 3446-3456.
［22］BOUTAHAR N, REYNAUD E, LASSABLIERE F, et al. Brain-derived neurotrophic factor inhibits cell cycle reentry but not endoplasmic reticulum stress in cultured neurons following oxidative or excitotoxic stress ［J］. Journal of Neuroscience Research, 2010, 88 (10): 2263-2271.
［23］CALABRESE F, ROSSETTI A C, RACAGNI G, et al. Brain-derived neurotrophic factor: a bridge between inflammation and neuroplasticity ［J］. Frontiers in Cellular Neuroscience, 2014, 8 (12): 430-436.
［24］MOROTTI M, VINCENT K, BRAWN J, et al. Peripheral changes in endometriosis-associated pain ［J］. Human Reproduction Update, 2014, 20 (5) : 717-736.
［25］CRUZ DUARTE P, ST-JACQUES B, MA Weiya. Prostaglandin E2 contributes to the synthesis of brain-derived neurotrophic factor in primary sensory neuron in ganglion explant cultures and in a neuropathic pain model ［J］. Experimental Neurology, 2012, 234 (2) : 466-481.
［26］代淑红，马正良．钾氯共转运体-2和痛觉过敏关系的研究进展 ［J］．国际麻醉学与复苏杂志，2015，36 （6）：543-546．
［27］GUPTA S, GHULMIYYAH J, SHARMA R, et al. Power of proteomics in linking oxidative stress and female infertility ［J］. BioMed Research International, 2014 (2014): 916212-91638.
［28］DORFMAN M D, KERR B, GARCIA-RUDAZ C, et al. Neurotrophins acting via TRKB receptors activate the JAGGED1-NOTCH2 cell-cell communication pathway to facilitate early ovarian development ［J］. Endocrinology, 2011, 152 (12): 5005-5016.
［29］BUYUK E, SEIFER D B. Follicular-fluid neurotrophin levels in women undergoing assisted reproductive technology for different etiologies of infertility ［J］. Fertility and Sterility, 2008, 90 (5): 1611-1615.
［30］ZHANG Q-y, GUAN Q, WANG Y, et al. BDNF Val66Met polymorphism is associated with Stage III-IV endometriosis and poor in vitro fertilization outcome ［J］. Human Reproduction (Oxford, England), 2012, 27 (6): 1668-1675.
［31］BARCENA DE ARELLANO M L, ARNOLD J, LANG H, et al. Evidence of neurotrophic events due to peritoneal endometriotic lesions ［J］. Cytokine, 2013, 62 (2): 253-261.
［32］WESSELS J M, KAY V R, LEYLAND N A, et al. Assessing brain-derived neurotrophic factor as a novel clinical marker of endometriosis ［J］. Fertility and Sterility, 2016, 105 (1): 119-128.e1.
相似文献/References:
[1]苏慧明,徐燕,李晶,等.E-钙粘附素在子宫内膜异位症盆腔腹膜病灶的表达[J].中国计划生育和妇产科,2010,(01):0.
SU Hui-ming,XU Yan,LI Jing,et al.[J].Chinese Journal of Family Planning & Gynecotokology,2010,(3):0.
[2]李桂兰.青春期子宫内膜异位症的诊治进展[J].中国计划生育和妇产科,2010,(03):0.
[3]韦晓娜,覃红萍.孕三烯酮配伍小剂量米非司酮治疗子宫内膜异位症64例效果观察[J].中国计划生育和妇产科,2010,(04):0.
[4]李成龙,冷金花.子宫内膜异位症与雌、孕激素受体关系的研究进展[J].中国计划生育和妇产科,2010,(04):0.
[5]关铮.深部浸润型子宫内膜异位症相关问题探讨[J].中国计划生育和妇产科,2011,(04):0.
[6]张瑞霞,刘增娟,谢伟,等.腹腔镜诊断盆腔子宫内膜异位症及对不孕症患者的疗效观察[J].中国计划生育和妇产科,2012,(02):0.
ZHANG Rui-xia,LIU Zeng-juan,XIE Wei,et al.[J].Chinese Journal of Family Planning & Gynecotokology,2012,(3):0.
[7]梁寿珺,范余娟,黄尹,等.血管内皮生长因子+936TC基因多态性同子宫内膜异位症遗传易感性的Meta分析[J].中国计划生育和妇产科,2012,(04):0.
LIANG Shou-jun,FAN Yu-juan*,HUANG Yin,et al.[J].Chinese Journal of Family Planning & Gynecotokology,2012,(3):0.
[8]范俊,栾少红,李晓林,等.口服避孕药在子宫内膜异位症治疗中的作用[J].中国计划生育和妇产科,2013,(02):0.
FAN Jun,LUAN Shao-hong,LI Xiao-lin,et al.[J].Chinese Journal of Family Planning & Gynecotokology,2013,(3):0.
[9]柴明涵,董白桦.左炔诺孕酮宫内缓释系统的临床应用[J].中国计划生育和妇产科,2014,(03):0.
[10]李素红,冯春蝶,付秀虹,等.Treg细胞及Foxp3在子宫内膜异位症患者的表达及临床意义[J].中国计划生育和妇产科,2014,(04):0.
LI Su-hong,FENG Chun-die,FU Xiu-hong,et al.[J].Chinese Journal of Family Planning & Gynecotokology,2014,(3):0.
[11]洪玮,段华*,汪沙,等.BDNF及TrKB在子宫内膜异位症在位内膜和异位病灶组织中的表达及意义[J].中国计划生育和妇产科,2018,(3):32.
HONG Wei,DUAN Hua*,WANG Sha,et al.Expression and significance of BDNF and TrKB in eutopic and ectopic endometrium of endometriosis[J].Chinese Journal of Family Planning & Gynecotokology,2018,(3):32.
[12]吴亚男,李红霞*,孟宪宁,等.子宫内膜异位症及卵巢癌患者血清脑源性神经营养因子水平的表达及意义[J].中国计划生育和妇产科,2018,(9):32.
WU Ya-nan,LI Hong-xia*,MENG Xian-ning,et al.Expression and significance of serum BDNF in patients with endometriosis and ovarian cancer[J].Chinese Journal of Family Planning & Gynecotokology,2018,(3):32.